Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine added to standard therapy for persistent Helicobacter pylori infection
IRCT20190326043119N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetylcysteine in Helicobacter pylori infection (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Side effects and Stool antigen. Started Aug 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20190326043119N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190326043119N1.